This is a preview of subscription content, log in via an institution to check access.
REFERENCE
The Medicines Company.New Publication Shows Angiomax Significantly Reduces Initial Hospital Costs by $572 Per Patient Compared to Conventional Therapy in Moderate and High-Risk ACS Patients. Media Release: 19 Nov 2008. Available from: URL: http://www.themedco.com
Rights and permissions
About this article
Cite this article
Bivalirudin decreases hospital costs. Pharmacoecon. Outcomes News 567, 10 (2008). https://doi.org/10.2165/00151234-200805670-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805670-00017